UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000023295
Receipt number R000026852
Scientific Title prevension of SSI by very low-dose naloxone
Date of disclosure of the study information 2016/09/01
Last modified on 2020/01/24 18:05:33

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

prevension of SSI by very low-dose naloxone

Acronym

naloxone and SSI

Scientific Title

prevension of SSI by very low-dose naloxone

Scientific Title:Acronym

naloxone and SSI

Region

Japan


Condition

Condition

colorectal surgery

Classification by specialty

Gastrointestinal surgery Anesthesiology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

very low-dose naloxone infusion may prevent the development of SSI after remifentanil based anesthesia in colorectal surgery

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Incidence of postoperative SSI

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification

NO

Dynamic allocation

NO

Institution consideration


Blocking


Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Medicine

Interventions/Control_1

Administration of Saline as control from the start of anesthesi to the end of surgery

Interventions/Control_2

Administration of very low-dose naloxone(0.25ug/kg/hr)under remifentanil based anesthesia from strat of anesthesia to the end of surgery

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

90 years-old >

Gender

Male and Female

Key inclusion criteria

Colorectal cancer surgety in respective institusion

Key exclusion criteria

Reoperation
patients with ireus tube
emergency operation
patients who declined

Target sample size

300


Research contact person

Name of lead principal investigator

1st name Manzo
Middle name
Last name Suzuki

Organization

Nippon Medical School Musashikosugi Hospital

Division name

Anesthesiology

Zip code

211-8533

Address

1-396 kosugi-tyo Nakaharaku Kawasaki

TEL

044-733-5181

Email

manzo@nms.ac.jp


Public contact

Name of contact person

1st name Yoshiharu
Middle name
Last name Kameda

Organization

Nippon Medical School Musashikosugi Hospital

Division name

syomuka

Zip code

211-8533

Address

1-396 kosugi-tyo Nakaharaku Kawasaki

TEL

044-733-5181

Homepage URL


Email

kameda@nms.ac.jp


Sponsor or person

Institute

Nippon Medical School Musashikosugi Hospital

Institute

Department

Personal name



Funding Source

Organization

Only Departmental Source

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

IRB committee Musashikosugi hospital nippon Medical school

Address

1-396 Kosugi-cho Nakaharaku Kawasaki

Tel

044-733-5181

Email

kameda@nms.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

日本医科大学武蔵小杉病院
日本医科大学多摩永山病院


Other administrative information

Date of disclosure of the study information

2016 Year 09 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2016 Year 08 Month 01 Day

Date of IRB

2016 Year 04 Month 01 Day

Anticipated trial start date

2016 Year 09 Month 10 Day

Last follow-up date

2020 Year 08 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2016 Year 07 Month 22 Day

Last modified on

2020 Year 01 Month 24 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000026852